Clinical Trial Update: Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm [Phase 3]

View source ↗

Summary

A Phase 3 trial compared amiodarone, sotalol, and placebo for maintaining sinus rhythm after conversion from atrial fibrillation. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Amiodarone (amiodarone)
• Sotalol (Sotalol)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Atrial Fibrillation, Cerebrovascular Accident | Phase 3 | Status: COMPLETED